- Formosa Chemicals reported a preliminary net loss of NT$5.49 billion for the first nine months of 2025.
- The company also recorded a preliminary operating loss of NT$3.16 billion during the same period.
- Preliminary revenue was reported at NT$222.03 billion.
- Loss per share was preliminarily reported at NT$0.94.
- Analyst ratings for Formosa Chemicals currently include 2 buy recommendations, 6 hold recommendations, and 3 sell recommendations.
A look at Formosa Chemicals & Fibre Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have issued a comprehensive assessment on Formosa Chemicals & Fibre Corporation, providing insights into its long-term prospects. The company has received a top score for its value, indicating that it is considered financially attractive by experts in the field. Moreover, with a strong momentum score, Formosa Chemicals & Fibre is showing robust performance trends that could bode well for its future growth.
While the company scored lower in categories like dividend, growth, and resilience, the high scores in value and momentum suggest that investors may still find Formosa Chemicals & Fibre to be a compelling investment opportunity. With a focus on manufacturing and marketing petrochemical products, nylon fiber, and rayon staple fiber, the company positions itself as a key player in Taiwan and the broader Asian market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
